Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS

@inproceedings{Elden2010Ataxin2IP,
  title={Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS},
  author={Andrew C. Elden and Hyung-Jun Kim and Michael P. Hart and Alice S Chen-Plotkin and Brian S Johnson and Xiaodong Fang and Maria Armakola and Felix Geser and Robert H. Greene and Min Min Lu and Arun Padmanabhan and D. V. Clay and L. F. McCluskey and L. B. Elman and Denise Juhr and Peter J Gruber and Udo R{\"u}b and Georg Auburger and John Q. Trojanowski and Virginia M. Y. Lee and Vivianna M Van Deerlin and Nancy M Bonini and Aaron D Gitler},
  booktitle={Nature},
  year={2010}
}
The causes of amyotrophic lateral sclerosis (ALS), a devastating human neurodegenerative disease, are poorly understood, although the protein TDP-43 has been suggested to have a critical role in disease pathogenesis. Here we show that ataxin 2 (ATXN2), a polyglutamine (polyQ) protein mutated in spinocerebellar ataxia type 2, is a potent modifier of TDP-43 toxicity in animal and cellular models. ATXN2 and TDP-43 associate in a complex that depends on RNA. In spinal cord neurons of ALS patients… CONTINUE READING
Highly Influential
This paper has highly influenced 47 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 370 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 35 references

a-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity

  • Gitler, D A.
  • Nature Genet
  • 2009

the FUS about TDP-43

  • C. Lagier-Tourenne, Cleveland, D. W. Rethinking ALS
  • Cell 136, 1001–1004
  • 2009

Similar Papers

Loading similar papers…